The global Chiral Chemicals Market is projected to achieve a substantial size, reaching $149.95 billion by 2030, exhibiting a notable CAGR of 9.8% from 2023 to 2030. The escalating demand for chiral chemicals is fueled by factors including a burgeoning population, shrinking arable land, and the impact of changing climate conditions on food security. This upward trajectory underscores the market's significance in addressing critical challenges and adapting to evolving environmental dynamics.
The Chiral Chemicals Market size is predicted to reach $149.95 billion by 2030 with a CAGR of 9.8% from 2023-2030.
Chiral chemical refers to a chemical compound with an asymmetrical carbon atom in the molecule's center. It can be summarized as a molecule that is not identical to its mirror image. These mirror images are known as enantiomers that have left-hand and right-hand non-superimposable configurations.
The demand for chiral chemicals is increasing, owing to the growing population, declining arable land, and changing climate conditions related to food security across the globe. In addition, chiral chemicals are used in the production of herbicides, pesticides, plant growth regulators, fungicides, and pheromones for optimum agricultural productivity, which in turn contributes to market growth. Also, in the growing demand in the pharmaceutical industry is also driving the growth of chiral chemicals market, as the chiral chemicals are used in the synthesis process for the development of drugs for cancer therapies,
antihistamines, antivirals, anorexics, antibiotics, and anti-diabetics.
However, rising environmental issues such as industrial pollution due to the massive use of chiral compounds in chemical factories and limited availability of raw materials are expected to restrain the growth of the market during the forecast period. On the other hand, various market players have been involved in the research & and development of chiral hormone chemicals, anti-infective chemicals, cardiovascular chemicals, central nervous system chemicals, antidepressants, and respiratory chemicals are expected to create lucrative growth opportunities for the chiral chemicals market players in the
future.
The chiral chemicals market size has been segmented based on separation technique, technology, application, and geography. Based on the separation technique, the market is classified into high-performance liquid chromatography (HPLC), ultra-high-performance liquid chromatography (UHPLC), supercritical fluid chromatography (SFC), and simulated moving bed (SMB). Based on technology, the market is divided into traditional separation methods, asymmetric preparation methods, biological separation methods, and others. The asymmetric preparation method segment is further classified into asymmetric synthesis method and asymmetric catalysis method. Based on application, the market is grouped into pharmaceuticals, agrochemicals, food & and beverage, cosmetics, and others. The geography breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.
Asia-Pacific region holds the lion's share of the chiral chemicals market at present and is expected to boost the market growth during the forecast period. The growing population in countries such as China, India, and Indonesia coupled with the increase in the demand for food is encouraging agricultural activities. This is further driving the demand for the chiral chemicals market in the agriculture sector in the region.
The chiral chemicals market includes various market players such as Chiral Technologies, Corden Pharma International, Clariant, BASF SE, Daicel Chiral Technologies, Boulder Scientific Company, Cambrex Corporation, Chiral Quest (Suzhou) Co., Ltd., Chiral BioSciences Ltd., Beckman Coulter, Agilent Technologies, Inc., Alps Pharmaceutical Ind. Co Ltd., and Buchler. These manufacturers are actively indulging in acquisitions, product & and technology innovations, and collaborations to enhance their productivity and increase their growth as well as geographical reach.
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing offers one pricing dimension: Product Access, billed in Units at no cost. There are no tiers, instance sizes, or usage add-ons to choose from. You subscribe once to gain access to the product. The single Unit measure grants entry to the market analysis report. Because pricing is Free, there is nothing that scales with quantity or usage. Once your subscription is confirmed, the report is delivered digitally to your registered email address, typically within 24 to 48 hours.
Top-of-mind questions for buyers
What does one Product Access Unit actually give me?
One Unit grants access to the Chiral Chemicals Market Analysis 2023-2030 report. It is a single access grant, not a per-user or per-seat count. Because the listing is Free, one Unit covers your entry to the report content without any quantity that scales cost.
How do I receive the report after I subscribe?
The report is delivered digitally to your registered email address. Files come in formats such as PDF, Excel, or Word, sent by email or as a download link. Delivery usually happens within 24 to 48 hours after your access is confirmed.
Does my cost change if I access the report more often or need updates?
No. The single Product Access Unit is Free, so nothing scales with how often you open the report. There are no usage add-ons or overage charges tied to access frequency. Customized or updated studies fall outside this access and would be arranged separately with the vendor.
www.nextmsc.com+1
Helpful?
Vendor refund policy
Not applicable - product available free of charge.
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
The global Chiral Chemicals Market is expected to achieve a valuation of $150 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 10% from 2023 to 2030. The escalating demand for chiral chemicals can be attributed to factors such as the expanding global population, diminishing arable land, and evolving climate conditions affecting food security worldwide.
Chiral by N-21 AI is a clinical-grade agentic AI platform for Medicare Advantage and Dual-Eligible risk adjustment. It improves coding accuracy, reduces RADV exposure, and protects RAF revenue through a closed-loop, human-governed workflow spanning the entire HCC lifecycle, from suspecting and coding to evidence validation and RADV audit support. Every diagnosis is linked to explainable, audit-ready clinical evidence, enabling accurate, defensible RAF capture. HIPAA-compliant, SOC 2 Type II, and deployable securely within your AWS environment.
60-minute live analyst briefing on the Chiral Chemicals Market (2026–2035), helping specialty chemical and pharmaceutical leaders optimize AWS-cloud roadmaps for predictive manufacturing, R&D intelligence, and supply chain resilience.